| Responsabile |
Progetto |
| Maria Grazia Andreassi |
Validation of miRNAs identified via miRNome NGS analysis in bicuspid aortic valve aortopathy (MIRANA) |
| Giuseppina Basta |
PROteomic and Transcriptional analysis of HEpatocellular carcinoma cell line-secreted microvesicles for the identification of a molecular SIgnature (PROTHESI) |
| Gloria Bertoli |
MiRNAs with high degree centrality are potential theranostic molecules in breast cancer (HDC BC miRNAs) |
| Giuseppe Biamonti |
Comparative Analyses of DROSHA recruitment and Local Gene Expression Alteration at DNA damage induced by Replicative Stress (CADreGA) |
| Ida Biunno |
Genome-wide methylation analysis of Multiple Sclerosis (MS) associated risk genes and pathogenic pathways in MS-derived iPSCs (MS-MethiPS) |
| Diana Boraschi |
MEmory MOnocytes: a link between Rheumatoid Arthritis and ATherosclerosis (MEMORAT) |
| Matteo Caleo |
Omics approaches for the characterization of novel glioma therapies (GLIOMICS) |
| Sebastiano Cavallaro |
Application of human iPSC-derived motor neurons for the development of personalized treatments of ALS patients (iPSCforTreatALS) |
| Alfredo Ciccodicola |
Multi-omic approaches for analysis and modulation of signalling pathways induced by methylglioxal in microvascular retinal cells (ASPIRE) |
| Ingrid Cifola |
Epigenome and Transcriptome profiling of human iPS cells to identify new therapeutic biomarkers involved in Myotonic Dystrophy Type-1 (MIMOSA) |
| Mauro Cozzolino |
mRNA localization profiling to unravel C9orf72 toxicity in ALS (ProALS) |
| Francesco Cucca |
Going from broad leukocyte to cell-specific expression profiling to further dissect autoimmune disease pathogenesis (SpeMReg2) |
| Igea D' Agnano |
INtegration of exosome mirnome/proteome Signature for IDEntification of specific GlioBlastoMa biomarkers (INSIDE-GBM) |
| Giovanni D' Angelo |
Signalling pathways integrating secretory pathway into cellular homeostasis network: a study based on transcriptional profiling (SecSiNet) |
| Domenica D' Elia |
Scouting cross-kingdom transfer: effect of exogenous plant microRNA on the expression of human genes involved in ageing-related diseases (SCKT) |
| Mario De Felice |
Tackling Pancreatic Adenocarcinomas growth promoting cancer stem cell differentiation (DiThe) |
| Claudio De Lazzari |
Heart Failure: "in silico" and "in vitro" mesenchymal stem cell study (HFsvMSCS) |
| Giuseppina De Simone |
Study of the Extracellular Interactome of human Carbonic Anhydrase IX (SEICA) |
| Elisa Di Pasquale |
(CARDIOLAMINOMICS II) |
| Francesca Fusco |
TranscriptOMIC strategy to identify the altered signal pathways in patients with severe forms of Incontinentia pigmenti (OMIC-IP) |
| Fernando Gianfrancesco |
Cell-based Omics approaches to dissect the molecular pathway underlying a severe form of Paget's disease of bone (COnCePT) |
| Carmela Gianfrani |
(MoHLACeDi) |
| Chiara Lanzuolo |
Deciphering the role of heterochromatin conformation in prostate cancer progression (CANCER) |
| Francesco M. Lasorsa |
Omics investigations of AGC1 deficiency pathogenesis in iPS cells (OMIxAGC1D) |
| Patrizia Lavia |
Interaction network-guided approaches to synthetic lethality and synergic combination therapy in cancer (Synlether) |
| Elena Levantini |
Bmi1 as a master proto-oncogene in Small and Non Small Cell Lung Cancer (MILCA) |
| Giuseppe Manco |
(ProTeoMA2) |
| Pierluigi Mauri |
Proteomic investigations of regulatory T cells in tumoral subjects (PITRe) |
| Alessandra Mezzelani |
Ochratoxin-A neurotoxicity: molecular and epigenetic mechanisms and their possible role in autism spectrum disorder (OTANEXT) |
| Cesare Montecucco |
Neuroregeneration studied by Transcriptomics and Imaging (NeT) |
| Ettore Mosca |
Integrative Mutational Analysis of patient-derived Breast Cancer Initiating Cells to disentangle tumor genetic complexity and identify actionable targets for precision medicine (BCIC-IMA) |
| Antonio Musio |
Cohesin dysfunction in Cornelia de Lange syndrome (CdLS) |
| Alessandro Orro |
Omics and computational approaches to understand molecular mechanisms involved in the rescue of F508Δ-CFTR mediated by novel classes of active compounds (Omics4CF) |
| Claudio Passananti |
Cell-based Omics approaches to identify pathways implicated in Duchenne Muscular Dystrophy by the use of therapeutic artificial genes (ZincOmics) |
| Graziano Pesole |
Understanding the mechanism of action of MLK3-JNK2 pathway and its application to Cystic Fibrosis and other protein misfolding disorders (MOAR) |
| Ernesto Picardi |
Investigating ADAR2 deregulation in sporadic ALS by single cell RNA sequencing of differentiated human motor neurons (ADRENAL) |
| Ennio Prosperi |
PCNA acetylation as a novel tumor biomarker through analysis of Pcna-targeted cell lines carrying specific mutations (PATBAT) |
| M. Patrizia Stoppelli |
p53-and-Fra-1-regulated transcriptional networks, secretome changes and paracrine effects on cancer-associated fibroblasts in nutlin-treated breast cancer cells (NUTLINOMICS) |
| Ileana Zucchi |
Tumor Interomic Networks in mammary gland, kidney and blood vessel organoids (StemCELLOmics) |